Frank R. Cruz

2 articles

Chemours Company Faces Securities Fraud Class Action Over Opteon Demand Claims

A securities fraud class action lawsuit alleges Chemours made misleading statements regarding Opteon product demand, causing a stock drop. Investors have until December 7, 2026, to file lead plaintiff

Business Wire · 2026-10-09 20:11

Chemours Shareholders Solicited for Securities Fraud Class Action Over Opteon Demand Claims

The Law Offices of Frank R. Cruz filed a class action against Chemours alleging misleading statements on Opteon product demand and 2026 guidance, resulting in an 18.63% stock decline.

FinancialContent · 2026-10-09 18:11